{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:46:08Z","timestamp":1779313568172,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>SYNGAP1<\/jats:italic>\n                      -related disorder (SRD) is a rare neurodevelopmental disorder caused by genetic variants. A major challenge is the characterization of SRD, which requires assessment of several outcomes.\u00a0We considered natural history data from the Citizen database on 65 patients with SRD in eight data domains: demographics, genetics, growth parameters, standardized clinical scales, developmental skills, neurological examinations, hospitalizations, and seizures. Exploratory analysis tools such as visualizations, summary statistics, and non-parametric statistical modeling were utilized.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Age at SRD diagnosis (median [IQR]\u2009=\u20093 [2, 5] years; [min, max]\u2009=\u2009[1, 17] years) was similar by sex.\u00a0No evidence of a high frequency allele change in\n                      <jats:italic>SYNGAP1<\/jats:italic>\n                      was found, indicating no dominant variant in this patient population. Growth parameters of SRD children appeared normal in terms of height, weight, and head circumference. Developmental data were indicative of delayed development and language reversion. Standardized assessment data were largely sparse. Neurological exam data demonstrated ataxia and muscle tone issues. Hospitalization data highlighted substantial healthcare burden, largely due to seizures; absence, atonic, and myoclonic seizures were the most common types.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Citizen data provide important insights into the natural course of SRD. Our findings not only provide utility in clinical practice of SRD but also contribute valuable insights to guide the development of SRD clinical trials. Limitations to our analysis include sparsity of standardized clinical scales data, crude statistical methodology, and bias induced by patients with older ages of diagnoses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03918-7","type":"journal-article","created":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T12:36:32Z","timestamp":1753619792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of retrospective natural history data collected from patients with SYNGAP1-related disorders: a preliminary examination of the Citizen database"],"prefix":"10.1186","volume":"20","author":[{"given":"Matthew R.","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Misko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1626-2588","authenticated-orcid":false,"given":"Oleksandr","family":"Sverdlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,27]]},"reference":[{"key":"3918_CR1","unstructured":"American Speech-Language-Hearing Association. \u201cCommunication Milestones: Birth to 1 Year.\u201d www.asha.org, www.asha.org\/public\/developmental-milestones\/communication-milestones-birth-to-1-year\/."},{"issue":"2","key":"3918_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/humu.22248","volume":"34","author":"MH Berryer","year":"2013","unstructured":"Berryer MH, Hamdan FF, Klitten LL, et al. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency. Hum Mutat. 2013;34(2):385\u201394. https:\/\/doi.org\/10.1002\/humu.22248.","journal-title":"Hum Mutat"},{"issue":"4","key":"3918_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2012.08.045","volume":"151","author":"JP Clement","year":"2012","unstructured":"Clement JP, Aceti M, Creson TK, et al. Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell. 2012;151(4):709\u201323. https:\/\/doi.org\/10.1016\/j.cell.2012.08.045.","journal-title":"Cell"},{"issue":"7","key":"3918_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/ng.2646","volume":"45","author":"GL Carvill","year":"2013","unstructured":"Carvill GL, Heavin SB, Yendle SC, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet. 2013;45(7):825\u201330. https:\/\/doi.org\/10.1038\/ng.2646.","journal-title":"Nat Genet"},{"key":"3918_CR5","unstructured":"Genetic Engineering & Biotechnology News (GEN). (2023). Gene therapy team wins grant to further research on rare SYNGAP-1 genetic disorder. https:\/\/www.genengnews.com\/news\/gene-therapy-team-wins-grant-to-further-research-on-rare-syngap-1-genetic-disorder\/"},{"issue":"6","key":"3918_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa0805392","volume":"360","author":"FF Hamdan","year":"2009","unstructured":"Hamdan FF, Gauthier J, Spiegelman D, et al. Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med. 2009;360(6):599\u2013605. https:\/\/doi.org\/10.1056\/NEJMoa0805392.","journal-title":"N Engl J Med"},{"issue":"1","key":"3918_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-019-9276-y","volume":"11","author":"A Jimenez-Gomez","year":"2019","unstructured":"Jimenez-Gomez A, Niu S, Andujar-Perez F, et al. Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression. J Neurodev Disord. 2019;11(1): 18. https:\/\/doi.org\/10.1186\/s11689-019-9276-y.","journal-title":"J Neurodev Disord"},{"key":"3918_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108500","volume":"127","author":"T Lo Barco","year":"2022","unstructured":"Lo Barco T, De Gaetano L, Santangelo E, et al. SYNGAP1-related developmental and epileptic encephalopathy: the impact on daily life. Epilepsy Behav. 2022;127: 108500. https:\/\/doi.org\/10.1016\/j.yebeh.2021.108500.","journal-title":"Epilepsy Behav"},{"issue":"8","key":"3918_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/jmedgenet-2015-103451","volume":"53","author":"C Mignot","year":"2016","unstructured":"Mignot C, von St\u00fclpnagel C, Nava C, et al. Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy. J Med Genet. 2016;53(8):511\u201322. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103451.","journal-title":"J Med Genet"},{"issue":"10","key":"3918_CR10","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1002\/ajmg.a.37189","volume":"167A","author":"MJ Parker","year":"2015","unstructured":"Parker MJ, Fryer AE, Shears DJ, et al. De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability. Am J Med Genet A. 2015;167A(10):2231\u20137. https:\/\/doi.org\/10.1002\/ajmg.a.37189.","journal-title":"Am J Med Genet A"},{"issue":"11","key":"3918_CR11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/jcpp.13565","volume":"63","author":"A Pickles","year":"2022","unstructured":"Pickles A, Wright N, Bedford R. Predictors of language regression and its association with subsequent communication development in children with autism. J Child Psychol Psychiatry. 2022;63(11):1243\u201351. https:\/\/doi.org\/10.1111\/jcpp.13565.","journal-title":"J Child Psychol Psychiatry"},{"key":"3918_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1321282","volume":"12","author":"J Ribeiro-Constante","year":"2024","unstructured":"Ribeiro-Constante J, Trist\u00e1n-Noguero A, Mart\u00ednez Calvo FF, et al. Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy. Front Cell Dev Biol. 2024;12: 1321282. https:\/\/doi.org\/10.3389\/fcell.2024.1321282.","journal-title":"Front Cell Dev Biol"},{"key":"3918_CR13","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405\u201324","DOI":"10.1038\/gim.2015.30"},{"issue":"6","key":"3918_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200105","volume":"9","author":"M Rong","year":"2023","unstructured":"Rong M, Benke T, Zulfiqar Ali Q, Aledo-Serrano \u00c1, Bayat A, Rossi A, Devinsky O, Qaiser F, Ali AS, Fasano A, Bassett AS, Andrade DM. Adult Phenotype of SYNGAP1-DEE. Neurol Genet. 2023;9(6): e200105. https:\/\/doi.org\/10.1212\/NXG.0000000000200105.","journal-title":"Neurol Genet"},{"issue":"2","key":"3918_CR15","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1212\/WNL.0000000000006729","volume":"92","author":"DRM Vlaskamp","year":"2019","unstructured":"Vlaskamp DRM, Shaw BJ, Burgess R. SYNGAP1 encephalopathy: a distinctive generalized developmental and epileptic encephalopathy. Neurology. 2019;92(2):e96\u2013107. https:\/\/doi.org\/10.1212\/WNL.0000000000006729.","journal-title":"Neurology"},{"key":"3918_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.seizure.2018.12.020","volume":"65","author":"C von St\u00fclpnagel","year":"2019","unstructured":"von St\u00fclpnagel C, Hartlieb T, Borggr\u00e4fe I, et al. Chewing induced reflex seizures (\u201ceating epilepsy\u201d) and eye closure sensitivity as a common feature in pediatric patients with SYNGAP1 mutations: review of literature and report of 8 cases. Seizure. 2019;65:131\u20137. https:\/\/doi.org\/10.1016\/j.seizure.2018.12.020.","journal-title":"Seizure"},{"issue":"5","key":"3918_CR17","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/epi.17913","volume":"65","author":"K Wiltrout","year":"2024","unstructured":"Wiltrout K, Brimble E, Poduri A. Comprehensive phenotypes of patients with SYNGAP1-related disorder reveals high rates of epilepsy and autism. Epilepsia. 2024;65(5):1428\u201338. https:\/\/doi.org\/10.1111\/epi.17913.","journal-title":"Epilepsia"},{"key":"3918_CR18","unstructured":"World Health Organization. \u201cMotor Development Milestones.\u201d www.who.int, www.who.int\/tools\/child-growth-standards\/standards\/motor-development-milestones."},{"key":"3918_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.761473","volume":"15","author":"H Zhang","year":"2021","unstructured":"Zhang H, Yang L, Duan J, et al. Phenotypes in children with SYNGAP1 encephalopathy in China. Front Neurosci. 2021;15: 761473. https:\/\/doi.org\/10.3389\/fnins.2021.761473.","journal-title":"Front Neurosci"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03918-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03918-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03918-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T01:02:14Z","timestamp":1753664534000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03918-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,27]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3918"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03918-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4010297\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,27]]},"assertion":[{"value":"1 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients were asked to complete and sign a consent form upon entry into Citizen.\u00a0This study was conducted under the approval of the Novartis IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employed (YL, OS, AM) or have been employed (MS) by Novartis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}